Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             151 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 EDITORIAL BOARD
28 S1 p.
artikel
2 O-30 ALCOHOL-HARM PARADOX IN LATIN AMERICA: HOW TO STUDY IT DESPITE DATA LIMITATIONS? THE CHILEAN EXPERIENCE Roblero, Juan Pablo

28 S1 p.
artikel
3 O-37 AMOXICILLIN-CLAVULANATE INDUCED LIVER INJURY: TEN YEARS EXPERIENCE FROM LATINDILI REGISTRY. Hernandez, Nelia

28 S1 p.
artikel
4 O-25 ASSESSMENT OF MODELS FOR PREDICTING RESPONSE TO CORTICOIDS TREATMENT IN ALCOHOL-ASSOCIATED HEPATITIS: A GLOBAL COHORT STUDY Idalsoaga, Francisco

28 S1 p.
artikel
5 O-8 CHARACTERIZATION AND EPIDEMIOLOGICAL CHANGES OF PATIENTS WITH HEPATITIS C VIRUS TREATED IN THE CHILEAN PUBLIC HEALTH SYSTEM FROM 2016 TO 2021. Salazar, Luis

28 S1 p.
artikel
6 O-12 CHARACTERIZATION AND UTILIZATION OF HCV-POSITIVE DONORS IN ARGENTINA Mendizabal, Manuel

28 S1 p.
artikel
7 O-2 CHARACTERIZATION OF SERUM LEVELS OF BILE ACIDS, EXTRACELLULAR VESICLES AND ITS CARGO IN ALCOHOL-ASSOCIATED LIVER DISEASE Arnold, Jorge

28 S1 p.
artikel
8 O-41 CIRRHOSIS IN PATIENTS WITH ALFA 1 ANTITRYPSIN DEFICIENCY; WHAT ARE WE MISSING? Hevia, Francisco

28 S1 p.
artikel
9 O-39 CLINICAL CHARACTERISTICS AND OUTCOME OF DRUG-INDUCED LIVER INJURY DUE TO ANTINEOPLASTIC AND BIOLOGICAL AGENTS Bessone, Fernando

28 S1 p.
artikel
10 O-4 CLINICAL, HISTOLOGICAL AND SEROLOGICAL FEATURES OF AUTOIMMUNE-LIKE ACUTE LIVER INJURY AFTER SARS-COV-2 VACCINATION Lopez, Marlene Padilla

28 S1 p.
artikel
11 O-19 COLLABORATIVE CARE TOWARDS MICROELIMINATION OF HEPATITIS C VIRUS IN A DIALYSIS POPULATION IN SOUTHERN BRAZIL Cheinquer, Hugo

28 S1 p.
artikel
12 O-42 COSTA RICA NATIONAL NEWBORN SCREENING LABORATORY´S EXPERIENCE IN DIAGNOSING ALPHA-1 ANTITRYPSIN DEFICIENCY Solano-Vargas, Mariela

28 S1 p.
artikel
13 O-31 DIAGNOSTIC PERFORMANCE OF BAVENO VII CRITERIA FOR EXCLUSION OF ESOPHAGEAL VARICES: A RETROSPECTIVE STUDY Campos, Williams Celedonio

28 S1 p.
artikel
14 O-22 DIFFERENTIAL MUTATION PATTERN ASSOCIATED WITH HEPATITIS B E ANTIGEN SEROCONVERSION BETWEEN SUBGENOTYPE F1b CLUSTERS: POTENTIAL ROLE IN PATHOGENESIS Martínez, Micaela

28 S1 p.
artikel
15 O-1 ECONOMIC IMPACT OF LONG-TERM ALBUMIN INFUSIONS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS AND UNCOMPLICATED ASCITES FROM THE BRAZILIAN PUBLIC AND PRIVATE HEALTHCARE SYSTEMS PERSPECTIVES Terra, Carlos

28 S1 p.
artikel
16 O-6 ENHANCED METABOLISM OF AROMATIC AMINO ACIDS AND LOW-DIVERSITY GUT MICROBIOTA: SIGNATURES OF HEPATIC ENCEPHALOPATHY IN DECOMPENSATED CIRRHOTIC PATIENTS FROM WESTERN MEXICO Baltazar-Díaz, Tonatiuh Abimael

28 S1 p.
artikel
17 O-35 EPIDEMIOLOGY, CLINICAL AND TISSUE CHARACTERISTICS OF A LARGE COHORT OF NAFLD/NASH FROM SOUTH AMERICA Ortiz, Jhon Prieto

28 S1 p.
artikel
18 O-18 ETHNIC DISPARITIES IN HISPANIC POPULATION WITH ALCOHOL ASSOCIATED LIVER DISEASE AND TRANSPLANT ENLISTED PATIENTS: A RETROSPECTIVE STUDY OF TWO LARGE DATABASES IN THE UNITED STATES FROM 2011-2018 Ayares, Gustavo

28 S1 p.
artikel
19 O-21 EVIDENCE OF SUBOPTIMAL PUBLIC HEALTH POLICIES ON HEPATOCELLULAR CARCINOMA IN THE AMERICAS: A HUGE DEBT OF OUR REGION Díaz, Luis Antonio

28 S1 p.
artikel
20 O-32 FULMINANT AUTOIMMUNE HEPATITIS: CLINICAL PRESENTATION, OUTCOME AND PROGNOSTIC FACTORS. Villamil, Alejandra

28 S1 p.
artikel
21 O-38 FULMINANT WILSON: A WELL-DEFINED ENTITY. HOW TO DIAGNOSE IT QUICKLY TO PREVENT MORTALITY Hevia, Francisco

28 S1 p.
artikel
22 O-23 HEPATITIS B VIRUS STATUS OF ORGAN DONORS IN ARGENTINA Anders, Maria

28 S1 p.
artikel
23 O-26 IMMUNE PROFILING PROVIDES A SET OF 5 CYTOKINES TO DETECT HEPATOCELLULAR CARCINOMA RELATED TO VIRAL HEPATITIS IN SOUTH AMERICAN PATIENTS Debes, Jose

28 S1 p.
artikel
24 O-15 INFECTIONS BY MULTI-DRUG RESISTANT BACTERIA WERE INDEPENDENTLY ASSOCIATED WITH HOSPITAL MORTALITY IN CIRRHOTICS WITH ACUTE DECOMPENSATION: A PROSPECTIVE STUDY ON 433 ADMISSIONS Ruffillo, Gabriela

28 S1 p.
artikel
25 O-5 INTEGRATED ANALYSIS OF ARCHAEAL, FUNGAL AND PROTOZOAN GUT TRANSCRIPTOME IN METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN ARGENTINA Suárez, Bárbara

28 S1 p.
artikel
26 O-7 LIVER TOXICITY OF TYROSINE KINASE INHIBITORS: A DESCRIPTIVE ANALYSIS FROM SLATINDILI NETWORK Hernández, Nelia

28 S1 p.
artikel
27 O-16 MELD-NA AND MELD3.0 HAVE THE BEST PERFORMANCE TO PREDICT THE 28-DAY RISK OF DEATH IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS IN THE MEXICAN POPULATION Tijera, Fátima Higuera-De La

28 S1 p.
artikel
28 O-20 MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF HEPATITIS B VIRUS SUBGENOTYPE F1b CLUSTERS: UNRAVELING ITS ROLE IN HEPATOCARCINOGENESIS Elizalde, María Mercedes

28 S1 p.
artikel
29 O-14 NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CORONARY HEART DISEASE Cattaneo, Máximo

28 S1 p.
artikel
30 OP-5 ALCOHOL-ASSOCIATED HEPATITIS IN LATIN AMERICA: RESULTS FROM THE AH-LATIN STUDY Díaz, Luis Antonio

28 S1 p.
artikel
31 O-34 PATIENT AND GRAFT SURVIVAL IN RECIPIENTS OF DE NOVO SIMULTANEOUS LIVER-KIDNEY TRANSPLANTATION Garmendia, Agustina Martínez

28 S1 p.
artikel
32 OP-3 CLINICAL PRESENTATION AND CAUSATIVE AGENTS OF IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY IN URUGUAY: FIRST DECADE OF EXPERIENCE. Hernandez, Nelia

28 S1 p.
artikel
33 O-13 PERFORMANCE OF PRE-TRANSPLANT CRITERIA IN PREDICTION OF HEPATOCELLULAR CARCINOMA PROGRESSION AND WAITLIST DROPOUT Piñero, Federico

28 S1 p.
artikel
34 OP-4 IMPLEMENTATION OF A RE-LINKAGE TO CARE STRATEGY IN PATIENTS WITH CHRONIC HEPATITIS C WHO WERE LOST TO FOLLOW-UP IN LATIN AMERICA Mendizabal, Manuel

28 S1 p.
artikel
35 O-24 PIRFENIDONE PREVENTS NEOPLASTIC LESIONS DEVELOPMENT BY OXIDATIVE, FIBROGENIC, ANTIPROLIFERATIVE AND EPIGENETIC MECHANISMS REGULATION IN A MODEL OF CHEMICAL HEPATOCARCINOGENESIS Miranda-Roblero, Hipólito Otoniel

28 S1 p.
artikel
36 OP-2 PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS ASSOCIATION WITH PHYSICAL ACTIVITY LEVELS AMONG ADULTS IN CHILE Pettinelli, Paulina

28 S1 p.
artikel
37 O-33 PREVALENCE OF HIGH-RISK NON-ALCOHOLIC STEATOHEPATITIS ACCORDING TO THE FAST® INDEX IN A GROUP OF DIABETIC PATIENTS Burak-Leipuner, Andrés

28 S1 p.
artikel
38 O-40 PROGNOSTIC ROLE OF MAGNETIC RESONANCE OF THE ABDOMEN WITH INTRAVENOUS CONTRAST AND CHOLANGIORESONANCE IN PRIMARY SCLEROSING CHOLANGITIS: OUR EXPERIENCE Grove, Roy López

28 S1 p.
artikel
39 O-43 RISK FACTORS FOR CANCER DEVELOPMENT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS Braga, Michelle Harriz

28 S1 p.
artikel
40 O-10 SIMILAR RISK RECLASSIFICATION OF HCC RECURRENCE BETWEEN THE AFP SCORE AND METROTICKET 2.0 AT LISTING AND AT LAST REASSESSMENT Piñero, Federico

28 S1 p.
artikel
41 O-17 STUDY OF THE ASSOCIATION BETWEEN SERUM LEVELS OF SYSTEMIC INFLAMMATORY MARKERS AND ADVANCED FIBROSIS STAGE IN INFECTED PATIENTS WITH HEPATITIS DELTA VIRUS GENOTYPE 3 Campos, Mauricio

28 S1 p.
artikel
42 O-9 THE CHANGING EPIDEMIOLOGY OF HEPATOCELLULAR CARCINOMA IN SOUTH AMERICA: A REPORT FROM THE SOUTH AMERICAN LIVER RESEARCH NETWORK Estupinan, Enrique Carrera

28 S1 p.
artikel
43 O-11 THE PUBLIC HEALTH POLICIES REDUCE THE LONG-TERM BURDEN OF ALCOHOL-ASSOCIATED LIVER DISEASE WORLDWIDE: DEVELOPMENT OF A PREPAREDNESS INDEX Díaz, Luis Antonio

28 S1 p.
artikel
44 O-36 UTILITY OF DRIED BLOOD SAMPLES FOR HEPATITIS C VIRUS GENOTYPING AMONG HCV/HIV-COINFECTED INDIVIDUALS Flores, Geane Lopes

28 S1 p.
artikel
45 P-120 ANTHROPOMETRIC AND METABOLIC PROFILE IN NON-ALCOHOLIC FATTY LIVER DISEASE de Prado, Lara Ramos

28 S1 p.
artikel
46 P- 25 ANTIOXIDANT EFFECT OF MORINGA OLEIFERA IN A MURINE MODEL OF NONALCOHOLIC STEATOHEPATITIS Monraz-Méndez, Alejandra

28 S1 p.
artikel
47 P-114 APPLICATION OF THE DONOR RISK INDEX IN LIVER TRANSPLANTATION IN THE MAIN TRANSPLANT CENTER IN PERU Padilla-Machaca, P.Martin

28 S1 p.
artikel
48 P-37 ASSESSMENT OF METABOLIC ASSOCIATED FATTY LIVER DISEASE, ALCOHOLIC LIVER DISEASE, AND DUAL DAMAGE IN APPARENTLY HEALTHY BLOOD BANK INDIVIDUALS Lira-Vera, Jorge Emilio

28 S1 p.
artikel
49 P- 99 ASSOCIATION OF LIVER ABNORMALITIES WITH DISEASE SEVERITY IN COVID-19 Hinojosa, Jhankarla

28 S1 p.
artikel
50 P- 28 ATORVASTATIN SHOWS ANTI-PROMOTOR AND ANTI-NEOANGIOGENIC EFFECT IN HEPATOCELLULAR CARCINOMA DEVELOPMENT IN VIVO AND IN VITRO MODEL BY INHIBITING TGF-β1/pERK SIGNALING PATHWAY Ridruejo, Ezequiel

28 S1 p.
artikel
51 P-116 AUTOIMMUNE DISEASES ASSOCIATED WITH AUTOIMMUNE HEPATITIS: EXPERIENCE IN TWO PARAGUAYAN CENTERS. Otazú, Florencia

28 S1 p.
artikel
52 P- 71 BACTERIAL INFECTIONS IN CIRRHOTIC PATIENTS: ARE WE FACING AN EPIDEMIOLOGICAL CHANGE? Sofía, Bulaty

28 S1 p.
artikel
53 P- 9 BIOMARKERS OF THE BACTERIAL, VIRAL AND HUMAN GUT TRANSCRIPTOME IN METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN ARGENTINA Mascardi, María Florencia

28 S1 p.
artikel
54 P-110 BIOPSY IN FOCAL LIVER LESIONS: CORRELATION FROM CLINICAL TO HISTOPATHOLOGY Carrera, Enrique

28 S1 p.
artikel
55 P-66 CARDIOVASCULAR RISK PROFILE AND ATHEROSCLEROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE Oliveira, Maria Eduarda de Almeida

28 S1 p.
artikel
56 P-27 CELLULAR EFFECTS OF IN VITRO LIPID OVERLOAD ON HEPATIC STELLATE CELLS AND HEPATOCYTES. Campos-Espinosa, Adriana

28 S1 p.
artikel
57 P- 91 CHANGES IN EARLY VISUAL PERCEPTION IN PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY Hernández, José Luis Pérez

28 S1 p.
artikel
58 P- 89 CHARACTERISTICS AND SURVIVAL OF PATIENTS WITH LIVER CIRRHOSIS AT A REFERRAL CENTER IN PARAGUAY Morán, Elías

28 S1 p.
artikel
59 P- 97 CHARACTERIZATION OF PATIENTS INFECTED WITH HEPATITIS C IN 2 REFERENCE CENTERS IN PARAGUAY, FROM APRIL 2000 TO SEPTEMBER 2021 Mongelos, José

28 S1 p.
artikel
60 P- 69 CHRONIC HEPATITIS B: EPIDEMIOLOGICAL CHARACTERISTICS, EVOLUTION AND PREVALENT PHASES, IN REFERENCE CENTERS IN PARAGUAY Colarte, Mirian

28 S1 p.
artikel
61 P- 102 CLINICAL CHARACTERISTICS OF LIVER CIRRHOSIS SECONDARY TO METABOLIC SYNDROME AND COMPARISON WITH ETHYL CIRRHOSIS Martínez, Laura

28 S1 p.
artikel
62 P- 30 CLINICAL FEATURES, TREATMENT, AND SURVIVAL OF PATIENTS WITH BUDD-CHIARI SYNDROME IN A HEPATOLOGY COLOMBIAN CENTER Morales, Ximena

28 S1 p.
artikel
63 P- 39 CLINICAL SIGNIFICANCE OF GRADE 1 HEPATIC ENCEPHALOPATHY IN PATIENTS HOSPITALIZED FOR COMPLICATIONS OF CIRRHOSIS Narciso-Schiavon, Janaína Luz

28 S1 p.
artikel
64 P- 75 COMPARISON OF EUS-GUIDED COIL PLUS CYANOACRYLATE VS CONVENTIONAL CYANOACRYLATE TECHNIQUE IN THE MANAGEMENT OF ACUTE GASTRIC VARICEAL BLEEDING. WHICH ONE IS BETTER? Carvajal, Aldo

28 S1 p.
artikel
65 P-49 CONCENTRATION OF IL-12 AND CXCL-10 IN CHRONIC LIVER DISEASES Hernandez-Santillan, Marisela

28 S1 p.
artikel
66 P-130 CONGENITAL PORTOSYSTEMIC SHUNTS: EXPERIENCE IN A THIRD LEVEL CHILDREN`S HOSPITAL Wisniacki, Micaela

28 S1 p.
artikel
67 P-121 CORRELATION BETWEEN HEPATOPULMONARY SYNDROME AND OXYGEN SATURATION PULSE OXIMETRY IN CIRRHOTIC PATIENTS Christo, Dayana

28 S1 p.
artikel
68 P-38 CRYPTOGENIC CHRONIC HEPATITIS: LOOKING FOR AN ETIOLOGICAL DIAGNOSIS Lopes, Guilherme Cançado Grossi

28 S1 p.
artikel
69 P-2 DE NOVO LIPOGENESIS MARKERS ARE INVOLVED IN METABOLIC ASSOCIATED FATTY LIVER DISEASE PROGRESSION IN BTBR OB/OB MICE Opazo-Rios, Lucas

28 S1 p.
artikel
70 P- 105 DETECTION OF HEPATITIS D VIRUS IN PATIENTS WITH CHRONIC HEPATITIS B FROM SOUTH AMERICA. Pisano, María Belén

28 S1 p.
artikel
71 P-60 DETERMINATION OF THE PREVALENCE OF HEPATITIS C VIRUS USING THE RAPID MONTEBIO HCV TEST IN A HIGH-RISK POPULATION OF HOSPITAL DEL SALVADOR, CHILE. Carvajal, Alejandro

28 S1 p.
artikel
72 P- 78 DIETHYlNITROSAMINE AND 2-ACETYLAMINOFLUORENE CHRONIC ADMINISTRATION LEADS TO BIOCHEMICAL, HISTOLOGIC AND GENETIC CHANGES RELATED TO HEPATOCELLULAR CARCINOMA IN WISTAR RATS Sánchez-Meza, Jaime

28 S1 p.
artikel
73 P- 80 DIFFERENTIAL EXPRESSION OF MATRIX METALLOPROTEINASE 7 IN CHRONIC LIVER DISEASES de Oca-Angeles, Daniel Montes

28 S1 p.
artikel
74 P- 21 DOCOSAHEXAENOIC ACID AND ITS DERIVATIVE MARESIN1 IMPROVE CHRONIC LIVER DAMAGE ASSOCIATED WITH THE PROMOTION OF APOPTOSIS PATHWAYS AND LIVER REGENERATION IN A SPRAGUE-DAWLEY MODEL. Zúñiga-Hernández, Jessica

28 S1 p.
artikel
75 P- 26 EFFECT OF PROTEIN X OF THE HEPATITIS B VIRUS AND HEXACHLOROBENZENE ON LIVER CELL GROWTH DYSREGULATION Deza, Zahira

28 S1 p.
artikel
76 P- 90 EFFECT OF THE DELIVERY OF WRITTEN INFORMATION ON DISEASE-RELATED KNOWLEDGE IN PATIENTS WITH CIRRHOSIS AND ASSOCIATED FACTORS Simian, Daniela

28 S1 p.
artikel
77 P- 76 ELEVATED FIBROSIS LEVEL IN PATIENTS COINFECTED WITH HEPATITIS AND COVID-19 DURING A LONGITUDINAL STUDY Da Silva, Lucas Lima

28 S1 p.
artikel
78 P- 84 ENDOSCOPIC ULTRASOUND GUIDED LIVER BIOPSY, IS IT READY FOR PRIMETIME? Hernández-Castro, Daniela

28 S1 p.
artikel
79 P- 45 ENDOSCOPIC ULTRASOUND SHEAR-WAVE ELASTOGRAPHY OF THE RIGHT AND LEFT HEPATIC LOBE PREDICTS LIVER CIRRHOSIS: A DIAGNOSTIC TRIAL Robles-Medranda, Carlos

28 S1 p.
artikel
80 P- 107 EPIDEMIOLOGY, CLINICAL AND TISSUE CHARACTERISTICS OF A LARGE COHORT OF NAFLD/NASH FROM SOUTH AMERICA Ortiz, Jhon Prieto

28 S1 p.
artikel
81 P- 77 EPIGENOME OF PATIENTS WITH LIVER FIBROSIS, WITH SUSTAINED VIRAL RESPONSE TO HCV IN LIVER BIOPSY AND LIQUID BIOPSY REVEALS THE ASSOCIATION OF DNA METHYLATION AND miRNA EXPRESSION WITH THE DEGREE OF SEVERITY De la Rosa-Bibiano, Ricardo

28 S1 p.
artikel
82 P-48 EVALUATION OF IL-1β AND IL-1RA IN PATIENTS WITH CHRONIC LIVER DISEASES Hernandez-Barragan, Abigail

28 S1 p.
artikel
83 P- 104 EXPERIENCE AND CARDIOVASCULAR OUTCOMES IN POST-LIVER TRANSPLANT PATIENTS AT A REFERENCE TRANSPLANT CENTER IN COLOMBIA Martinez, Carlos

28 S1 p.
artikel
84 P-8 EXTRACELLULAR VESICLE-DERIVED MICRORNA SIGNATURE IN HCV AND HCV/HIV PATIENTS WITH DIFFERENT STAGES OF LIVER FIBROSIS Cairoli, Victoria

28 S1 p.
artikel
85 P-16 FIRST MICRO ELIMINATION INTERVENTION OF HEPATITIS B &C IN INMATES OF THE EIGHT PRISONS IN THE PROVINCE OF MENDOZA, ARGENTINA Villar, Gabriela

28 S1 p.
artikel
86 P- 17 FRAILTY AND COVERT HEPATIC ENCEPHALOPATHY IN CIRRHOTIC PATIENTS AT A THIRD LEVEL HOSPITAL IN GUATEMALA Maldonado, Katherine

28 S1 p.
artikel
87 P- 51 HEALTH EDUCATION AND SEROPREVALENCE OF HEV IN RURAL AND PERI-URBAN POPULATION, WITH AGRICULTURAL ACTIVITY IN BAHIA – BRAZIL - PRELIMINARY DATA Bastos, Fernanda Anjos

28 S1 p.
artikel
88 P-53 HELICOBACTER PYLORI INFECTION IN PATIENTS WITH PEPTIC ULCER DISEASE AND CIRRHOSIS OF THE LIVER Fustamante, Jaime

28 S1 p.
artikel
89 P- 32 HEPATITIS A AND E VIRUSES IN CÓRDOBA, ARGENTINA: WASTEWATER-BASED EPIDEMIOLOGY AS A SILENT SENTINEL OF THE TREND OF VIRUS CIRCULATION IN THE COMMUNITY Fantilli, Anabella

28 S1 p.
artikel
90 P-70 HEPATITIS B IMMUNITY AMONG CHRONIC RENAL DISEASE UNDER HEMODIALYSIS Santos, Alanna Calheiros

28 S1 p.
artikel
91 P- 54 HEPATITIS C MICROELIMINATION IN FORMER DRUG USERS Gruz, Fernando

28 S1 p.
artikel
92 P- 64 HEPATITIS C VIRUS MICRO-ELIMINATION PROGRAM IN AN OPEN POPULATION Rodríguez-, Edgar

28 S1 p.
artikel
93 P-117 HEPATOBILIARY INJURIES: EXPERIENCE OF THE MULTIDISCIPLINARY COMMITTEE AT THE HOSPITAL DE ESPECIALIDADES EUGENIO ESPEJO (HEE) IN QUITO – ECUADOR Zambrano, Estibalys

28 S1 p.
artikel
94 P-118 HEPATOCELLULAR CARCINOMA. AN EXPERIENCE IN A TRANSPLANT CENTER IN COLOMBIA Varón, Adriana

28 S1 p.
artikel
95 P- 34 HEPATOCELLULAR CARCINOMA IN CHILE; A RETROSPECTIVE MULTICENTER STUDY OF 856 PATIENTS Norero, Blanca

28 S1 p.
artikel
96 P- 44 HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS IN A PARAGUAYAN LIVER REFERENCE CENTER: CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS Martínez, Lorena

28 S1 p.
artikel
97 P-123 HEPATOCELLULAR CARCINOMA SURVIVAL: EXPERIENCE OF THE MULTIDISCIPLINARY COMMITTEE AT HOSPITAL ESPECIALIDADES EUGENIO ESPEJO IN QUITO – ECUADOR Carrera, Enrique

28 S1 p.
artikel
98 P- 85 HIGHER LEVELS OF ALKALINE PHOSPHATASIS AFTER 6-MONTH TREATMENT WITH URSODEOXYCHOLIC ACID WERE ASSOCIATED WITH EVOLUTION TO ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE Dotta, Diogo Delgado

28 S1 p.
artikel
99 P1- HIGH VIRAL SUPPRESSION AND IMPROVED SAFETY PROFILE OF TENOFOVIR ALAFENAMIDE RELATIVE TO TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B PATIENTS TREATED FOR 5 YEARS Seto, Wai Kay

28 S1 p.
artikel
100 P-33 IMPACT OF SUSTAINED VIROLOGIC RESPONSE ON GLUCOSE PARAMETERS AMONG CHRONIC HEPATITIS C PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS Cheinquer, Hugo

28 S1 p.
artikel
101 P- 93 INTERVENTIONS AND CLINICAL OUTCOMES IN PATIENTS EXCLUDED FROM PRE-LIVER TRANSPLANT EVALUATION IN A SINGLE CENTER EXPERIENCE Amaya, Alejandra

28 S1 p.
artikel
102 P-40 IS THERE A DISTINCT PHENOTYPE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN LEAN AND OVERWEIGHT PATIENTS? Vanni, Denise Siqueira

28 S1 p.
artikel
103 P-7 LIVER INJURY AFTER COVID-19 VACCINATION COMPARED TO POST-INFLUENZA VACCINES: RETROSPECTIVE COHORT STUDY Lopez, Marlene Padilla

28 S1 p.
artikel
104 P- 79 LIVER TRANSPLANTATION FOR HEPATOCELLULAR, LOOKING FOR THE BETTER SELECTION CRITERIA. RESULTS FROM THE URUGUAYAN LIVER TRANSPLANT PROGRAM Coronado, Cinthya

28 S1 p.
artikel
105 P-119 LIVER TRANSPLANTATION IN ACUTE ON CHRONIC LIVER FAILURE (ACLF): RESULTS OF THE MAIN TRANSPLANT CENTER OF PERU Cabezas, Carmen Ana Cerron

28 S1 p.
artikel
106 P-129 LIVER TRANSPLANTATION IN PATIENTS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA. EXPERIENCE OF TWO CASES AT AN ARGENTINE HHT REFERRAL CENTER Serra, Marcelo

28 S1 p.
artikel
107 P-122 MAFLD PREVALENCE AND FACTORS ASSOCIATED WITH LIVER STEATOSIS IN PATIENTS WITH TRAUMATIC SPINAL CORD INJURY Coelho, Fernanda Barros Viana

28 S1 p.
artikel
108 P-52 MALNUTRITION IN COMPENSATED AND DECOMPENSATED LIVER CIRRHOSIS Curia, Andrea

28 S1 p.
artikel
109 P- 112 METABOLIC FATTY LIVER DISEASE: FIBROSIS AND SARCOPENIA FREQUENCIES AND CORRELATION Ferreira, Helen Cristine Saldanha

28 S1 p.
artikel
110 P-15 MMP-2 AND MMP-9 LEVELS IN ALCOHOLIC LIVER DISEASE, NON-ALCOHOLIC FATTY LIVER DISEASE AND CHRONIC HEPATITIS C Lemus-Peña, María

28 S1 p.
artikel
111 P- 111 MORTALITY ON LIVER TRANSPLANT WAITING LIST: ANALYSIS OF A TRANSPLANT CENTER IN COLOMBIA Torres, Cristina

28 S1 p.
artikel
112 P- 109 NON-INVASIVE ASSESSMENT OF FIBROSIS REGRESSION IN VIROLOGICAL RESPONDERS SUSTAINED BY HEPATITIS C VIRUS García, Dania Anaberta Campos

28 S1 p.
artikel
113 P-65 NOREPINEPHRINE INFUSION AS AN ALTERNATIVE TO ALBUMIN POST LARGE VOLUMEN PARACENTESIS IN CIRRHOTIC PATIENTS Morales-Mairena, Ernaldo

28 S1 p.
artikel
114 P-42 OBESITY AND ANTI-HBC IGG POSITIVITY INCREASE THE RISK OF HEPATOCELLULAR CARCINOMA IN A COHORT OF CHRONIC HEPATITIS C PATIENTS IN A TERTIARY OUTPATIENT CLINIC IN SÃO PAULO, BRAZIL Trazzi, Alexandre

28 S1 p.
artikel
115 P-14 OPTIMIZATION OF MOLECULAR METHODS FOR SARS-CoV-2 QUALITATIVE DETECTION AND GENOTYPING IN RESPIRATORY SPECIMENS FROM PATIENTS WITH LIVER DISEASE da Costa, Vanessa Duarte

28 S1 p.
artikel
116 P- 12 PATHOGENIC VARIANT OF PNPLA3 DOES NOT ASSOCIATE WITH HEPATOCELLULAR CARCINOMA IN SOUTH AMERICANS. A REPORT FROM THE ESCALON NETWORK Balderramo, Domingo

28 S1 p.
artikel
117 P-6 PATTERNS OF ANTIBIOTIC RESISTANCE IN PATIENTS WITH CIRRHOSIS AND SPONTANEOUS BACTERIAL INFECTIONS: ANALYSES OF THE MULTICENTER STUDY FROM ARGENTINA AND URUGUAY Marciano, Sebastián

28 S1 p.
artikel
118 P-10 PATTERNS OF PROGRESSION AND TREATMENT DISCONTINUATION IN A REAL LIFE LATIN AMERICAN PROSPECTIVE COHORT STUDY OF INTERMEDIATE-ADVANCED HEPATOCELLULAR CARCINOMA: SECOND INTERIM ANALYSIS Piñero, Federico

28 S1 p.
artikel
119 P- 43 PIRFENIDONE PREVENTS NEOPLASTIC LESIONS DEVELOPMENT BY OXIDATIVE, FIBROGENIC, ANTIPROLIFERATIVE AND EPIGENETIC MECHANISMS REGULATION IN A MODEL OF CHEMICAL HEPATOCARCINOGENESIS Miranda-Roblero, Hipólito Otoniel

28 S1 p.
artikel
120 P-3 PLASMA EXCHANGE WITH ALBUMIN INCREASES EFFECTIVE ALBUMIN LEVELS IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE Horrillo, Raquel

28 S1 p.
artikel
121 P- 108 POLYMORPHISMS OF HLA (LOCI DR 4*) IN HISPANICS AS RISK FACTOR FOR DE-NOVO AUTOIMMUNE HEPATITIS AFTER LIVER TRANSPLANTATION Varón, Adriana

28 S1 p.
artikel
122 P- 62 PREDICTION OF FIBROSIS PROGRESSION AND CLINICAL OUTCOMES WITH NON INVASIVE TESTS IN 10 YEARS FOLLOW UP OF PATIENTS WITH NON ALCOHOLIC STEATOHEPATITIS Altikes, Renato Gama

28 S1 p.
artikel
123 P-13 PREVALENCE, CHARACTERIZATION, AND SURVIVAL OF ACUTE ON CHRONIC LIVER FAILURE IN A LATIN AMERICAN COHORT:  A MULTICENTER STUDY Idalsoaga, Francisco

28 S1 p.
artikel
124 P-58 PREVALENCE OF CHRONIC VIRAL HEPATITIS TYPE C IN PEOPLE DEPRIVED OF THEIR LIBERTY IN THE CERESOS OF THE STATE OF VERACRUZ, MEXICO: TOWARDS MICRO-ELIMINATION Terrones, María Teresa Guzmán

28 S1 p.
artikel
125 P-61 PREVALENCE OF HEPATITIS E VIRUS INFECTION ON CIRRHOTIC PATIENT POPULATION FROM ROSARIO Acosta, Julián

28 S1 p.
artikel
126 P- 81 PREVALENCE OF HEV INFECTION IN HIV CARRIERS, PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND CIRRHOTIC PATIENTS Santos, Luan Henrique Paim

28 S1 p.
artikel
127 P-126 PREVALENCE OF LIVER FIBROSIS IN THE INFECTION BY THE HEPATITIS B AND C VIRUS IN GUATEMALA Sanchez, Abel

28 S1 p.
artikel
128 P- 103 PREVALENCE OF SARCOPENIA IN CIRRHOTIC PATIENTS IN AN OUTPATIENT SERVICE IN BRAZIL de Andrade, Carolina Pretti Tumang

28 S1 p.
artikel
129 P- 11 PROTUMORIGENIC GALECTINS 1 AND 3 ARE UPREGULATED IN THE LIVER OF MICE EXPOSED TO CONTINUOUS GROWTH HORMONE LEVELS Fuente, Santiago De La

28 S1 p.
artikel
130 P- 35 RELINKAGE OF PATIENTS WITH CHRONIC HEPATITIS C INFECTION IN THE CONTEXT OF THE COVID-19 PANDEMIC Sotera, Gisela Fabiana

28 S1 p.
artikel
131 P-36 RESULTS OF AN AUTOMATIC ALERT SYSTEM FROM MICROBIOLOGY TO LINK DIAGNOSIS TO TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C Mateu, Carlos Alventosa

28 S1 p.
artikel
132 P-4 RISK OF HCC IN SOUTH AMERICANS ASSOCIATED WITH TLL1 VARIANT SINGLE NUCLEOTIDE POLYMORPHISM Boonstra, Andre

28 S1 p.
artikel
133 P- 24 RISK OF MULTIPLE DRUG INTERACTIONS POTENTIALLY LINKED TO SAFETY IN PATIENTS RECEIVING PANGENOTYPIC DIRECT-ACTING ANTIVIRALS FOR THE TREATMENT OF HEPATITIS C Turnes, Juan

28 S1 p.
artikel
134 P-41 SARCOPENIA AS A PREDICTOR OF RISK OF MINIMAL HEPATIC ENCEPHALOPATHY IN PATIENTS WITH LIVER CIRRHOSIS Gutiérrez, Oscar Morales

28 S1 p.
artikel
135 P- 50 SEROPREVALENCE OF HEPATITIS E VIRUS IN HIV-INFECTED PATIENTS FROM ROSARIO, SANTA FE Acosta, Julián

28 S1 p.
artikel
136 P-31 SHORT-TERM EFFICACY AND SAFETY OF LOLA THERAPY IN PATIENTS WITH CIRRHOSIS AND MINIMAL HEPATIC ENCEPHALOPATHY: A REAL-LIFE COHORT STUDY Tijera, Fátima Higuera-De La

28 S1 p.
artikel
137 P 56- SHORT-TERM RESPONSE OF P300 EVOKED POTENTIAL IN PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY TREATED WITH L-ORNITHINE, L-ASPARTATE Pérez-Hernández, José Luis

28 S1 p.
artikel
138 P-19 SPLENIC IRON OVERLOAD IN PATIENTS WITH HEREDITARY HEMOCHROMATOSIS Yamasato, Maria Florencia

28 S1 p.
artikel
139 P- 57 SURVIVAL AND LIVER TRANSPLANTATION FOR PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE IN URUGUAY Elizondo, Martín

28 S1 p.
artikel
140 P-115 SUSCEPTIBILITY TO LIVER DAMAGE IN WOMEN DUE TO RISKY ALCOHOL CONSUMPTION. Pérez-Hernández, José Luis

28 S1 p.
artikel
141 P-23 TEST AND TREAT: PROFILE OF PATIENTS DIAGNOSED WITH HEPATITIS C IN THE PRISON SYSTEM OF PORTO ALEGRE, BRAZIL Emerim, Eduardo

28 S1 p.
artikel
142 P-29 THE LIVER IN AMYLOIDOSIS: AN ANALYSIS OF THE INSTITUTIONAL AMYLOIDOSIS REGISTRY Aguirre, María Adela

28 S1 p.
artikel
143 P-5 THREE-DIMENSIONAL SINGLE-CELL ATLAS OF LIVER TISSUE ARCHITECTURE Martinez, Dilan

28 S1 p.
artikel
144 P-124 TITLE: CLINICAL CHARACTERISTICS OF CIRRHOTIC PATIENTS WITH VARICEAL BLEEDING IN A SINGLE CENTER EXPERIENCE. DESCRIPTIVE STUDY Garzon, Martin

28 S1 p.
artikel
145 P- 63 TREATING HEPATITIS C (HCV) IN ADDICTION CENTERS IN OUR COMMUNITY: ANOTHER STEP TOWARDS MICROELIMINATION Blanco-Sampascual, Sonia

28 S1 p.
artikel
146 P- 113 TREATMENT OF CHRONIC HEPATITIS B IN TWO REFERENCE CENTERS IN PARAGUAY. Colarte, Mirian

28 S1 p.
artikel
147 P- 101 TREATMENT OF PATIENTS INFECTED WITH HEPATITIS C VIRUS IN TWO REFERENCE CENTERS IN PARAGUAY. Mongelós, José

28 S1 p.
artikel
148 P- 18 TREATMENT WITH BEVACIZUMAB IN HIGH OUTPUT CARDIAC FAILURE DUE TO SEVERE HEPATIC COMPROMISE IN HEREDITARY HEMORRHAGIC TELANGIECTASIA PATIENTS: OBSERVATIONAL COHORT STUDY Vazquez, Carolina

28 S1 p.
artikel
149 P- 73 ULTRASOUND VISUALIZATION OF THE LIVER Demirdjian, Ezequiel

28 S1 p.
artikel
150 P-67 USEFULNESS OF 3 DIFFERENT POINTS OF THE LIVER TO EVALUATE FIBROSIS BY TRANSITIONAL ELASTOGRAPHY Mairena, Ernaldo Morales

28 S1 p.
artikel
151 P- 82 VERY HIGH PREVALENCE OF STEATOSIS AND STRIKINGLY ELEVATED ANTIE VIRUS ANTIBODIES: RESULTS OF A LIVER DISEASE SCREENING CAMPAIGN Galimberti, Alceo

28 S1 p.
artikel
                             151 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland